123 related articles for article (PubMed ID: 6230876)
1. [Structure-activity relationship of hexamethylmelamine derivatives].
Su YZ; Pan QC; Sun MZ; Ren YF
Zhongguo Yao Li Xue Bao; 1983 Dec; 4(4):276-80. PubMed ID: 6230876
[No Abstract] [Full Text] [Related]
2. Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.
Morimoto M; Green D; Rahman A; Goldin A; Schein PS
Cancer Res; 1980 Aug; 40(8 Pt 1):2762-7. PubMed ID: 6771004
[No Abstract] [Full Text] [Related]
3. In vitro studies with hexamethylmelamine.
Rutty CJ; Connors TA
Biochem Pharmacol; 1977 Dec; 26(24):2385-91. PubMed ID: 413551
[No Abstract] [Full Text] [Related]
4. In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives.
Dubois J; Arnould R; Abikhalil F; Hanocq M; Atassi G; Ghanem G; Libert A; Lejeune FJ
Anticancer Res; 1990; 10(3):827-32. PubMed ID: 2114821
[TBL] [Abstract][Full Text] [Related]
5. Uptake and metabolism of hexamethylmelamine and pentamethylmelamine by L5178Y lymphoblasts in vitro.
Begleiter A; Grover J; Goldenberg GJ
Cancer Res; 1980 Dec; 40(12):4489-94. PubMed ID: 6777039
[No Abstract] [Full Text] [Related]
6. Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolism.
Ross D; Langdon SP; Gescher A; Stevens MF
Biochem Pharmacol; 1984 Apr; 33(7):1131-6. PubMed ID: 6424683
[TBL] [Abstract][Full Text] [Related]
7. [Hexamethylmelamine (Hexastat)].
Aabo K; Lund B
Ugeskr Laeger; 1984 Jan; 146(4):285-6. PubMed ID: 6422601
[No Abstract] [Full Text] [Related]
8. Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
Broggini M; Rossi C; Colombo T; D'Incalci M
Cancer Treat Rep; 1982 Jan; 66(1):127-33. PubMed ID: 6796267
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of the methylmelamines.
Rutty CJ; Abel G
Chem Biol Interact; 1980 Feb; 29(2):235-46. PubMed ID: 6766359
[TBL] [Abstract][Full Text] [Related]
10. Studies of the mode of action of antitumour triazenes and triazines-III. Metabolism studies on hexamethylmelamine.
Brindley C; Gescher A; Langdon SP; Broggini M; Colombo T; D'Incalci M
Biochem Pharmacol; 1982 Mar; 31(5):625-31. PubMed ID: 6805472
[TBL] [Abstract][Full Text] [Related]
11. In vitro cytotoxicity of imidazolyl-1,3,5-triazine derivatives.
Yaguchi S; Izumisawa Y; Sato M; Nakagane T; Koshimizu I; Sakita K; Kato M; Yoshioka K; Sakato M; Kawashima S
Biol Pharm Bull; 1997 Jun; 20(6):698-700. PubMed ID: 9212994
[TBL] [Abstract][Full Text] [Related]
12. Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
Foster BJ; Clagett-Carr K; Hoth D; Leyland-Jones B
Cancer Treat Rep; 1986 Mar; 70(3):383-9. PubMed ID: 3082512
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of hexamethylmelamine and pentamethylmelamine by liver microsomal preparations.
Ames MM; Sanders ME; Tiede WS
Life Sci; 1981 Oct; 29(15):1591-8. PubMed ID: 6795407
[No Abstract] [Full Text] [Related]
14. Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamine.
Connors TA; Cumber AJ; Ross WC; Clarke SA; Mitchley BC
Cancer Treat Rep; 1977 Aug; 61(5):927-8. PubMed ID: 408005
[No Abstract] [Full Text] [Related]
15. Changes in serum copper and zinc during treatment with anticancer drugs interfering with pyridoxal phosphate.
Slavik M; Narasimhan TR; Riley C; Slavik J
Adv Exp Med Biol; 1989; 258():235-42. PubMed ID: 2516708
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor action of phenylalanine derivatives of mechlorethamine (author's transl)].
Zhou JX; Liang HZ; Xu B
Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):121-8. PubMed ID: 6461211
[No Abstract] [Full Text] [Related]
17. Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.
Miller KJ; McGovern RM; Ames MM
Cancer Chemother Pharmacol; 1985; 15(1):49-53. PubMed ID: 3924426
[TBL] [Abstract][Full Text] [Related]
18. [The pharmacological properties of preparations from the aziridinyl triazine group].
Stukov AN; Filov VA; Kon'kov SA; Ivin BA
Eksp Klin Farmakol; 1996; 59(1):58-60. PubMed ID: 8704637
[TBL] [Abstract][Full Text] [Related]
19. Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites.
D'Incalci M; Erba E; Balconi G; Morasca L; Garattini S
Br J Cancer; 1980 Apr; 41(4):630-5. PubMed ID: 6770884
[TBL] [Abstract][Full Text] [Related]
20. [Action of the new modifier "Kokhedur" on the body].
Kozlova TA
Gig Sanit; 1974 Aug; 39(8):105-6. PubMed ID: 4218819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
